Events

New Horizons In ES-SCLC

A meeting proudly sponsored by Amgen, focusing on current treatments and future therapies for Extensive Stage Small Cell Lung Cancer (ES-SCLC).
Monday, August 12, 2024
6:30 pm
– 8:00 pm AEST

A meeting proudly sponsored by Amgen, with a theme focusing on current treatments and future therapies for Extensive Stage Small Cell Lung Cancer (ES-SCLC), chaired by A/Prof Surein Arulananda and co-chaired by Prof Nick Pavlakis.

Chairs

Dr

Rebecca Tay

MBBS (Hons), FRACP

Medical Oncologist, Royal Hobart Hospital / Icon Cancer Centre and TOGA Scientific Committee SCLC/Mesothelioma Co-Chair

A/Prof

Surein Arulananda

MBBS BMedSci MBA PhD FRACP

Deputy Director, Medical Oncology, Thoracic Oncology Trials Lead, Monash Health, Adjunct Associate Professor, Monash University, Basic and Translational Science Committee Member, IASLC

Speakers

Prof

Kate Sutherland

BSc PhD

Laboratory Head, The Walter and Eliza Hall Institute of Medical Research and TOGA Scientific Committee Translational Research Co-Chair

Prof

Michael Boyer

MBBS, FRACP

Chief Executive Officer at Chris O'Brien Lifehouse

Prof

Nick Pavlakis

BSc MBBS MMEd (Clin Epi) PhD FRACP

Medical Oncologist, Royal North Shore Hospital / Chair, TOGA Board of Directors

A/Prof

Sagun Parakh

BSc MBChB FRACP PhD

Medical Oncologist and Clinician Scientist, Austin Hospital

Thank you to our Sponsor

Event Recording